Jacobs Levy Equity Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$455K Buy
2024
Q1
Sell
2023
Q4
$227K Buy